Oxford Medical Products targets overweight individuals
Updated Date: Mon, 03 Mar 2025 00:00:00 EST
Updated Date: Mon, 03 Mar 2025 00:00:00 EST
FSCD therapy meets all endpoints in interim analysis
Scottish Medicines Consortium approves new option for mCRPC patients
Over the past year, a firestorm of debate has been swirling around the role of physician associates (PAs) […]
Researchers have developed a drug shown to significantly extend survival time for patients with glioblastoma, the most common […]
The BMA has announced plans to take legal action over an exam error that left some doctors facing […]
Nottingham University Hospitals NHS trust is investigating allegations that healthcare staff illegally accessed medical records of the victims […]
